Results 21 to 30 of about 178,708,228 (184)
São Paulo Medical Journal, 2020 BACKGROUND: Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is still the most prevalent type of osteonecrosis with clinical relevance. In Brazil, bisphosphonate use is high but there is a lack of epidemiological studies on BRONJ. OBJECTIVE: To
Aloizio Premoli Maciel +4 more
doaj +1 more source
Clinical Case Reports, 2023 Key Clinical Message Chronic use of bisphosphonates, in combination with immunosuppressive therapy, increases the risk of jaw osteonecrosis. When sepsis occurs in patients receiving bisphosphonate, osteonecrosis of the jaw should be considered a ...
Kazuhiko Iwasaki, Akihito Okazaki
doaj +1 more source
Frontiers in Endocrinology, 2021 BackgroundA causal relationship of bisphosphonate (BP) exposure with osteonecrosis of the jaw (ONJ) has been reported; however, a definite dose-dependent risk remains to be elucidated beyond current vague recommendations of 4-year oral BP for ONJ risk ...
Jung-Hyun Park +6 more
doaj +1 more source
Brazilian Journal of Otorhinolaryngology, 2022 Introduction: Increased incidence of localized osteonecrosis in the jaw bones caused by bisphosphanate use and reduced quality of life of the patients led researchers to diagnose the disease in the early period and to investigate the effective treatment ...
Onur Şahin +5 more
doaj +1 more source
Advances in Oral and Maxillofacial Surgery, 2023 Objective: The purpose of this study was to ascertain the correlation between COVID-19 infection and jaw osteonecrosis, along with the identification of risk factors that could be associated with the development of the condition. Another aim of our study
Mohd Aswad Khan +8 more
doaj +1 more source
, 2020 In the past, osteonecrosis of the jaw (ONJ) was generally reported with bisphosphonate drugs; hence, the term BRONJ (bisphosphonate-related osteonecrosis of the jaw) was initially proposed.
Bakr, Mahmoud M +7 more
core +1 more source
Journal of Medical Case Reports, 2011 Introduction Osteonecrosis of the jaw is a serious side effect in patients receiving nitrogen-containing bisphosphonates intravenously due to malignant diseases.
Ehrenfeld Michael +3 more
doaj +1 more source
Medication-Related Osteonecrosis: Why the Jawbone?
Dentistry Journal, 2023 Medication-related osteonecrosis of the jaw (MRONJ) has emerged as a complication of anti-resorptive medications. Despite its low incidence rate, this problem has gained attention in recent years due to its devastating consequences and lack of preventive
Sydney Kuehn +2 more
doaj +1 more source
Osteonecrosis of the jaw in a patient under treatment of osteoporosis with oral bisphosphonate
Autopsy and Case Reports, 2021 Although uncommon in patients under oral therapy, bisphosphonate-related osteonecrosis of the jaw (BRONJ) can be a very severe issue. Early intervention with surgical resection should be the preferable method of treating any stage of the disease ...
Marília A. Figueiredo +2 more
doaj
Dentistry Journal, 2018 The recent randomized trial, published by Raje et al., on Lancet Oncology is potentially practice changing. It proposes that denosumab is a valid alternative to zoledronic acid in the treatment of myeloma patients.
Vittorio Fusco +6 more
doaj +1 more source